389 related articles for article (PubMed ID: 33802165)
1. Arterial Blood Pressure Variability and Other Vascular Factors Contribution to the Cognitive Decline in Parkinson's Disease.
Pierzchlińska A; Kwaśniak-Butowska M; Sławek J; Droździk M; Białecka M
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802165
[TBL] [Abstract][Full Text] [Related]
2. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B
J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase (COMT) genetic variants are associated with cognitive decline in patients with Parkinson's disease.
Lin CH; Fan JY; Lin HI; Chang CW; Wu YR
Parkinsonism Relat Disord; 2018 May; 50():48-53. PubMed ID: 29439855
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
[TBL] [Abstract][Full Text] [Related]
5. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of cardiovascular dysautonomia and cognitive impairment between de novo Parkinson's disease and de novo dementia with Lewy bodies.
Oka H; Umehara T; Nakahara A; Matsuno H
BMC Neurol; 2020 Sep; 20(1):350. PubMed ID: 32948137
[TBL] [Abstract][Full Text] [Related]
8. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
9. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
[TBL] [Abstract][Full Text] [Related]
10. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
[TBL] [Abstract][Full Text] [Related]
11. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?
McDonald C; Newton JL; Burn DJ
Mov Disord; 2016 Jul; 31(7):937-46. PubMed ID: 27091624
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland.
Eerola J; Launes J; Hellström O; Tienari PJ
Neurosci Lett; 2002 Sep; 330(3):296-8. PubMed ID: 12270650
[TBL] [Abstract][Full Text] [Related]
13. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
14. [Homocysteine and its role in pathogenesis of Parkinson's disease and other neurodegenerative disorders].
Szadejko K; Szabat K; Ludwichowska A; Sławek J
Przegl Lek; 2013; 70(7):443-7. PubMed ID: 24167945
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.
Zoccolella S; Martino D; Defazio G; Lamberti P; Livrea P
Curr Vasc Pharmacol; 2006 Jul; 4(3):237-43. PubMed ID: 16842141
[TBL] [Abstract][Full Text] [Related]
16. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.
Park YW; Shin NY; Chung SJ; Kim J; Lim SM; Lee PH; Lee SK; Ahn KJ
Mov Disord; 2019 Nov; 34(11):1672-1679. PubMed ID: 31322758
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A
Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
[TBL] [Abstract][Full Text] [Related]
19. Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.
Hawkins KA; Emadi N; Pearlson GD; Winkler AM; Taylor B; Dulipsingh L; King D; Pittman B; Blank K
Metab Brain Dis; 2017 Jun; 32(3):849-857. PubMed ID: 28255864
[TBL] [Abstract][Full Text] [Related]
20. Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.
Robertson AD; Messner MA; Shirzadi Z; Kleiner-Fisman G; Lee J; Hopyan J; Lang AE; Black SE; MacIntosh BJ; Masellis M
Parkinsonism Relat Disord; 2016 Jan; 22():80-6. PubMed ID: 26639982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
